All are true about ESBL except –
**Core Concept**
Extended-Spectrum Beta-Lactamases (ESBLs) are enzymes produced by certain bacteria, such as E. coli and Klebsiella pneumoniae, that confer resistance to a broad spectrum of beta-lactam antibiotics, including third- and fourth-generation cephalosporins and aztreonam. These enzymes hydrolyze the beta-lactam ring of these antibiotics, rendering them ineffective.
**Why the Correct Answer is Right**
The correct answer is D because ESBL production is confirmed by testing the isolate's susceptibility to third- and fourth-generation cephalosporins. This is because ESBLs are specifically effective against these antibiotics. The Ambler classification (Option B) is indeed based on molecular structure, and it categorizes beta-lactamases into four classes (A, B, C, and D). However, this classification is not directly related to ESBL confirmation. ESBLs are typically resistant to carbapenems (Option A), which are a different class of beta-lactam antibiotics.
**Why Each Wrong Option is Incorrect**
**Option A:** Carbapenems are generally resistant to ESBLs, but this is not a reliable method for confirming ESBL production. Some ESBL-producing bacteria may retain susceptibility to carbapenems.
**Option B:** While the Ambler classification is based on molecular structure, it is not used to confirm ESBL production. The classification is more relevant to understanding the evolutionary relationships between different beta-lactamases.
**Option C:** The classification of ESBLs is not based solely on their susceptibility to third-generation cephalosporins. ESBLs can exhibit varying levels of resistance to different cephalosporins.
**Clinical Pearl / High-Yield Fact**
When testing for ESBL production, it is essential to use a combination of third- and fourth-generation cephalosporins, as ESBLs may exhibit varying levels of resistance to different antibiotics. This is a key consideration in the clinical management of ESBL-producing infections.
**✓ Correct Answer: D. 3rd & 4* g. cefalosporin sensivity testing is must to confirm the ESBL**